Ubaid Ayesha, Shakir Mohd, Ali Asghar, Khan Sobia, Alrehaili Jihad, Anwer Razique, Abid Mohammad
Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India.
Clinical Biochemistry Laboratory, Department of Biochemistry, School of Chemical and Life Science, Jamia Hamdard, New Delhi 110062, India.
Molecules. 2024 Dec 6;29(23):5777. doi: 10.3390/molecules29235777.
In response to the escalating crisis of antimicrobial resistance (AMR), there is an urgent need to research and develop novel antibiotics. This study presents the synthesis and assessment of innovative 4-aminoquinoline-benzohydrazide-based molecular hybrids bearing aryl aldehydes () and substituted isatin warheads (), characterized using multispectroscopic techniques with high purity confirmed by HRMS. The compounds were evaluated against a panel of clinically relevant antibacterial strains including the Gram-positive , , and and a Gram-negative bacterial strain. Preliminary screenings revealed that several test compounds had significant antimicrobial effects, with standing out as a promising compound. Additionally, demonstrated impressively low minimum inhibitory concentrations (MICs) in the range of (8-128 μg/mL) against the strains and . Upon further confirmation, not only showed bactericidal properties with low minimum bactericidal concentrations (MBCs) such as (8 μg/mL against ) but also displayed a synergistic effect when combined with the standard drug ciprofloxacin (CIP), highlighted by its FICI value of (0.375) against , while posing low toxicity risk. Remarkably, also inhibited a multidrug-resistant (MDR) bacterial strain, marking it as a critical addition to our antimicrobial arsenal. Computation studies were performed to investigate the possible mechanism of action of the most potent hybrid on biofilm-causing protein (PDB ID: 7C7U). The findings suggested that exhibits favorable binding free energy, which is supported by the MD simulation studies, presumably responsible for the bacterial growth inhibition. Overall, this study provides a suitable core for further synthetic alterations for their optimization as an antibacterial agent.
为应对日益严重的抗菌药物耐药性(AMR)危机,迫切需要研究和开发新型抗生素。本研究介绍了带有芳基醛()和取代异吲哚酮弹头()的创新型基于4-氨基喹啉-苯甲酰肼的分子杂化物的合成与评估,采用多光谱技术对其进行表征,并通过高分辨质谱(HRMS)确认其高纯度。对一系列临床相关抗菌菌株进行了评估,包括革兰氏阳性菌、和以及革兰氏阴性菌菌株。初步筛选显示,几种测试化合物具有显著的抗菌作用,其中表现突出,是一种有前景的化合物。此外,对菌株和显示出令人印象深刻的低最低抑菌浓度(MIC),范围为(8 - 128μg/mL)。进一步确认后,不仅显示出低最低杀菌浓度(MBC)的杀菌特性,如对的MBC为8μg/mL,而且与标准药物环丙沙星(CIP)联合使用时表现出协同效应,其对的FICI值为0.375,同时毒性风险较低。值得注意的是,还抑制了一种多重耐药(MDR)细菌菌株,这使其成为我们抗菌武器库中的重要补充。进行了计算研究,以探究最有效的杂化物对生物膜形成蛋白(PDB ID:7C7U)的可能作用机制。研究结果表明,具有良好的结合自由能,分子动力学(MD)模拟研究也支持这一点,这可能是其抑制细菌生长的原因。总体而言,本研究为进一步的合成改造提供了一个合适的核心,以便将其优化为一种抗菌剂。